TG Therapeutics rises 17% as 2025 revenue guidance, Q4 revenue beats expectations
by
Contributor since / Followers
Contributor since / Followers
2 months ago
mohd izzuan
- TG Therapeutics is up ~17% Monday after issuing 2025 revenue guidance above consensus and Q4 2024 revenue results that beat consensus.
- The biopharma is expecting revenue this year of ~$540M. Consensus is $534.45M.
- Revenue of $108.19M in the quarter beat expectations